Cubist Systematic Strategies’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-101,829
| Closed | -$8.66M | – | 2809 |
|
|
2020
Q3 | $8.66M | Sell |
101,829
-185,281
| -65% | -$9.37M | 0.13% | 196 |
|
|
2020
Q2 | $10.2M | Buy |
287,110
+283,310
| +7,456% | +$8.28M | 0.18% | 101 |
|
|
2020
Q1 | $51K | Sell |
3,800
-116,376
| -97% | -$1.96M | ﹤0.01% | 2007 |
|
|
2019
Q4 | $2.54M | Buy |
120,176
+27,325
| +29% | +$482K | 0.05% | 616 |
|
|
2019
Q3 | $1.23M | Sell |
92,851
-22,879
| -20% | -$336K | 0.02% | 879 |
|
|
2019
Q2 | $1.6M | Buy |
115,730
+112,723
| +3,749% | +$1.7M | 0.03% | 785 |
|
|
2019
Q1 | $58K | Sell |
3,007
-19,570
| -87% | -$315K | ﹤0.01% | 2084 |
|
|
2018
Q4 | $322K | Buy |
22,577
+155
| +0.7% | +$3.08K | 0.02% | 1237 |
|
|
2018
Q3 | $467K | Buy |
22,422
+22,322
| +22,322% | +$529K | 0.03% | 883 |
|
|
2018
Q2 | $2K | Sell |
100
-20,557
| -100% | -$413K | ﹤0.01% | 1751 |
|
|
2018
Q1 | $302K | Buy |
20,657
+18,440
| +832% | +$301K | 0.02% | 1147 |
|
|
2017
Q4 | $36K | Buy |
+2,217
| New | +$26.2K | ﹤0.01% | 1805 |
|
|
2017
Q2 | – | Sell |
-23,444
| Closed | -$152K | – | 1962 |
|
|
2017
Q1 | $152K | Buy |
+23,444
| New | +$119K | 0.01% | 1283 |
|
|
2016
Q3 | – | Sell |
-69,285
| Closed | -$161K | – | 1953 |
|
|
2016
Q2 | $161K | Buy |
+69,285
| New | +$232K | 0.01% | 1402 |
|
Cubist Systematic Strategies's IMMU Position: Q4 2020 in Review
Cubist Systematic Strategies sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 101,829 shares — an estimated $8.66M sold.
Cubist Systematic Strategies first reported a position in IMMU in Q2 2016 and held it in 14 quarters. The position peaked at $10.2M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Cubist Systematic Strategies reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Cubist Systematic Strategies sold 101,829 Immunomedics Inc shares in Q4 2020, an estimated $8.66M.
- Cubist Systematic Strategies first reported a position in Immunomedics Inc in Q2 2016 and held it in 14 quarters.
- Cubist Systematic Strategies's Immunomedics Inc position peaked at $10.2M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Cubist Systematic Strategies's 13F filing for Q4 2020, filed 16 Feb 2021.